Ophthalmology
circa 1550 BCE, Ancient Egypt, Ebers Papyrus (general visual impairment descriptions)
Macular degeneration, a condition affecting the central region of the retina, was observed and puzzled over by physicians for centuries before its anatomical basis was understood. Early healers attributed the gradual loss of central vision to humoral imbalances or aging of the eye's vital spirits. It was not until the development of the ophthalmoscope in the nineteenth century that clinicians could examine the retinal changes associated with the condition.
Historical Narrative
The earliest systematic observations of vision loss centered on the macula were embedded within broader ancient frameworks for understanding blindness and failing sight. Egyptian medical papyri, including the Ebers Papyrus dating to approximately 1550 BCE, catalogued various forms of visual impairment and prescribed remedies involving animal bile, honey, and mineral compounds applied to the eyes, though no distinction was drawn between conditions affecting central versus peripheral vision. Greek physicians, following Hippocratic tradition, attributed deteriorating eyesight in the elderly to a thickening or drying of the vitreous humor, the transparent gel believed to transmit visual spirit from the lens to the brain. Galen of Pergamon elaborated this framework in the second century CE, situating visual failure within his comprehensive humoral system and recommending dietary adjustments, purgatives, and topical applications to restore balance.
Throughout the medieval period, Islamic scholars preserved and extended Greco-Roman ophthalmic knowledge. Ibn Sina, writing in the eleventh century in his Canon of Medicine, described a range of conditions causing diminished vision in older patients, attributing them to a weakening of the visual faculty residing in the crystalline lens. Hunayn ibn Ishaq, the ninth-century physician and translator, produced influential treatises on the eye that were studied across Europe and the Islamic world, reinforcing the lens-centered model of vision and leaving the retina's specific role poorly understood.
The pivotal transformation in understanding came with the invention of the direct ophthalmoscope by Hermann von Helmholtz in 1851, which allowed physicians for the first time to peer inside the living eye and observe the retina directly. Within decades, clinicians began documenting distinctive changes at the posterior pole of the eye in elderly patients who had complained of distorted or lost central vision. The German ophthalmologist Otto Haab produced one of the earliest systematic descriptions of what he called senile macular degeneration in 1885, carefully detailing the drusen deposits and pigmentary disturbances he observed ophthalmoscopically. His work shifted medical attention decisively toward the retina and away from the lens as the locus of this form of visual decline.
In the early twentieth century, further refinement came through the contributions of researchers such as Josef Igersheimer and later Norman Ashton, who investigated the vascular and degenerative changes underlying retinal damage. The distinction between what would later be characterized as atrophic and exudative forms of the condition began to emerge during this period, as clinicians noted that some patients deteriorated slowly while others experienced rapid, dramatic vision loss accompanied by subretinal fluid and hemorrhage. Fluorescein angiography, introduced in the 1960s by Harold Novotny and David Alvis, revolutionized the ability to visualize retinal blood vessels and trace abnormal neovascular growth, providing researchers with unprecedented detail about the mechanisms driving the more aggressive presentations of the condition. These historical developments collectively transformed macular degeneration from an ill-defined complaint of old age into a specific, anatomically grounded disease entity, setting the stage for the laboratory and clinical investigations that would define the latter twentieth century.
Key Historical Figures
Historical narrative only — this page describes how Macular degeneration was understood historically. It is not medical advice and does not describe current diagnosis or treatment. Sourced from verified medical history references (NIH, Encyclopaedia Britannica, and standard medical history texts). See our medical disclaimer.